Dermatology · Chico, CA
NPI
1285781492
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
270 Cohasset Rd Ste 100
Chico, CA, 95926
Phone (530) 895-1396
Medicare paid, 2024
$408K
8,348 services
Medicare patients, 2024
868
Average age 76
Drug cost, 2024
$372K
1,196 prescriptions
Company payments, 2025
$936
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jacqueline M Losi-Sasaki was code 17003 (destruction skin lesion), 3,595 times for 505 patients. In total Jacqueline M Losi-Sasaki billed 8,348 services in 91 codes, and Medicare paid $408K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 3,595 | 505 | $5.37 | $19K |
| 99214 Office E&M - Established | Office | 1,097 | 650 | $90.90 | $100K |
| 17000 Destruction Skin Lesion | Office | 1,039 | 641 | $40.90 | $42K |
| 11102 Skin Biopsy | Office | 677 | 479 | $71.54 | $48K |
| 99213 Office E&M - Established | Office | 444 | 317 | $61.83 | $27K |
| 11103 Skin Biopsy | Office | 170 | 128 | $40.01 | $6,802 |
| 17004 Destruction Skin Lesion | Office | 141 | 114 | $126.87 | $18K |
| 99211 Office E&M - Established | Office | 73 | 69 | $17.36 | $1,267 |
| 17110 Destruction Skin Lesion | Office | 69 | 66 | $88.96 | $6,138 |
| 17263 Destruction Skin Lesion | Office | 67 | 52 | $143.18 | $9,593 |
| 13132 Wound Repair - All Levels | Office | 61 | 53 | $365.65 | $22K |
| 99212 Office E&M - Established | Office | 49 | 44 | $41.36 | $2,027 |
| J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 47 | 38 | $307.82 | $14K |
| 13121 Wound Repair - All Levels | Office | 46 | 40 | $319.52 | $15K |
| 96574 Skin | Office | 43 | 37 | $221.74 | $9,535 |
By year: 2022 $355K for 7,723 services; 2023 $407K for 8,411 services; 2024 $408K for 8,348 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| Q0112 All potassium hydroxide (koh) preparations | 27 | 25 | $5.71 | $154 |
Medicare prescription drug claims, 2024
In 2024, the drug Jacqueline M Losi-Sasaki prescribed most often to Medicare patients was Ketoconazole, with 134 prescriptions and refills. In total Jacqueline M Losi-Sasaki wrote 1,196 Medicare prescriptions that cost $372K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 134 | 161 | 72 | $2,652 |
| Mupirocin Generic | 115 | 116 | 78 | $629 |
| Ciclopirox Ciclopirox Olamine | 101 | 112 | 56 | $2,270 |
| Doxycycline Hyclate Generic | 80 | 86 | 60 | $934 |
| Triamcinolone Acetonide Generic | 68 | 75 | 49 | $325 |
| Clobetasol Propionate Generic | 67 | 70 | 46 | $3,284 |
| Levocetirizine Dihydrochloride Generic | 56 | 94 | 23 | $518 |
| Minoxidil Generic | 52 | 99 | 13 | $291 |
| Valacyclovir Valacyclovir Hcl | 45 | 49 | 24 | $1,198 |
| Acyclovir Generic | 40 | 41 | 34 | $163 |
| Metronidazole Generic | 35 | 47 | 20 | $1,746 |
| Nystatin Generic | 29 | 29 | 22 | $378 |
| Cephalexin Generic | 27 | 27 | 18 | $46.67 |
| Fluorouracil Generic | 23 | 24 | 15 | $1,376 |
| Doxycycline Monohydrate Generic | 21 | 45 | Under 11 | $287 |
Brand drugs: 69 claims; generic drugs: 1,127 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jacqueline M Losi-Sasaki $936 ($936 in general payments such as food, travel and fees) from 9 companies. The largest payer was Janssen Biotech, Inc. with $321.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 25 | $321 |
| Arcutis Biotherapeutics, Inc. ARQT | 8 | $159 |
| Abbvie Inc. ABBV | 7 | $140 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 4 | $95.94 |
| Mallinckrodt Hospital Products Inc. | 3 | $77.76 |
| Pfizer Inc. PFE | 3 | $53.63 |
| Galderma Laboratories, L.P. GALD.SW | 3 | $44 |
| Amgen Inc. AMGN | 1 | $29.62 |
| Lilly USA, LLC LLY | 1 | $15.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.